Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02318368
Title A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AVEO Pharmaceuticals, Inc, Biodesix
Indications

lung non-small cell carcinoma

Therapies

Erlotinib

Erlotinib + Ficlatuzumab

Age Groups: adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
UCSF Fresno Fresno California 93701 United States Details
Torrance Memorial Medical Center Redondo Beach California 90277 United States Details
Boca Raton Regional Hospital Lynn Cancer Institute Boca Raton Florida 33486 United States Details
University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach Deerfield Beach Florida 33442 United States Details
Kaiser Permanente Hawaii Honolulu Hawaii 96819 United States Details
Cancer Center of Acadiana Lafayette Louisiana 70503 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Valley Medical Group Paramus New Jersey 07652 United States Details
Queens Hospital Cancer Center Jamaica New York 11432 United States Details
Aultman Hospital Canton Ohio 44710 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
UPMC Cancer Center Cancer Pittsburgh Pennsylvania 15232 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
North Coast Cancer Institute Coffs Harbour New South Wales 2450 Australia Details
Concord Repatriation General Hospital Concord New South Wales 2139 Australia Details
Townsville Hospital Douglas Queensland 4814 Australia Details
Icon Cancer Care Southport Queensland 4215 Australia Details
Princess Alexandra Hospital Wolloongabba Queensland 4102 Australia Details
Flinders Medical Centre Bedford Park South Australia 5043 Australia Details
Eastern Health Box Hill Victoria 3128 Australia Details
Frankston Hospital Frankston Victoria 3199 Australia Details
Ballarat Oncology and Haematology Wendouree Victoria 3355 Australia Details
Tuen Mun Hospital Tuen Mun N.T Hong Kong Details
Queen Mary Hospital Pok Fu Lam Hong Kong Details
AO G.Rummo Benevento 82100 Italy Details
Policlinico S.Orsola Malpighi Bologna 40138 Italy Details
Istituti Ospitalieri di Cremona - Oncologia Cremona 26100 Italy Details
U.O.C. Oncologia Lucca 55100 Italy Details
IRCCS Ospedale S.Raffaele Milano 20132 Italy Details
Fondazione Salvatore Maugeri Pavia 27100 Italy Details
IRCCS Istituto Clinico Humanitas Rozzano MI 20089 Italy Details
Ospedale Treviglio-Caravaggio Treviglio BG 24047 Italy Details
Korea University Guro Hospital Guro-gu Seoul 152703 Korea, Republic of Details
Chungbuk National University Hospital Chungcheongbuk-do 362-711 Korea, Republic of Details
Chonnam National University Hwasun Hospital Jeonnam 519-763 Korea, Republic of Details
Severance Hospital, Yonsei Uni Seoul 120-752 Korea, Republic of Details
Samsung Medical Center Seoul 135-710 Korea, Republic of Details
John Hopkins Singapore International Medical Center Central Singapore 308433 Singapore Details
National Cancer Centre Singapore 169610 Singapore Details
Chung Shan Medical University Taichung 40201 Taiwan Details
China Medical University Hospital Taichung 40447 Taiwan Details
National Cheng Kung University Tainan 70403 Taiwan Details
National Taiwan University Hospital Taipei City 100 Taiwan Details
Taipei Veterans General Hospital Taipei City 11217 Taiwan Details
Taipei Medical University Taipei 11696 Taiwan Details
Chang Gung Medical Foundation Taoyuan City 333 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field